Bristol-Myers Ends Abilify MDL With Confidential Settlement
Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. Ltd. have reached a confidential global settlement with plaintiffs in multidistrict litigation over side effects of their antipsychotic drug Abilify, according to a case management...To view the full article, register now.
Already a subscriber? Click here to view full article